Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Glynne-Jones, MD
Mount Vernon Cancer Centre at Mount Vernon Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
72 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wansbeck General Hospital
Ashington, England, United Kingdom
- North Devon District Hospital
Barnstaple, England, United Kingdom
- Furness General Hospital
Barrow in Furness, England, United Kingdom
- Birmingham Heartlands Hospital
Birmingham, England, United Kingdom
- Good Hope Hospital
Birmingham, England, United Kingdom
- Queen Elizabeth Hospital at University Hospital of Birmingham Nhs Trust
Birmingham, England, United Kingdom
- Blackpool Victoria Hospital
Blackpool, England, United Kingdom
- Pilgrim Hospital
Boston, England, United Kingdom
- Bristol Haematology and Oncology Centre
Bristol, England, United Kingdom
- Queen'S Hospital
Burton-on-Trent, England, United Kingdom
- Cumberland Infirmary
Carlisle, England, United Kingdom
- Broomfield Hospital
Chelmsford, Essex, England, United Kingdom
- Gloucestershire Oncology Centre at Cheltenham General Hospital
Cheltenham, England, United Kingdom
- Castle Hill Hospital
Cottingham, England, United Kingdom
- Walsgrave Hospital
Coventry, England, United Kingdom
- Derbyshire Royal Infirmary
Derby, England, United Kingdom
- Doncaster Royal Infirmary
Doncaster, England, United Kingdom
- University Hospital of North Durham
Durham, England, United Kingdom
- Princess Alexandra Hospital
Essex, England, United Kingdom
- Royal Devon and Exeter Hospital
Exeter, England, United Kingdom
- Royal Bolton Hospital
Farnworth, England, United Kingdom
- Queen Elizabeth Hospital
Gateshead, England, United Kingdom
- Gloucestershire Royal Hospital
Gloucester, England, United Kingdom
- St. Luke'S Cancer Centre at Royal Surrey County Hospital
Guildford, England, United Kingdom
- Wycombe General Hospital
High Wycombe, England, United Kingdom
- Princess Royal Hospital at Hull and East Yorkshire Nhs Trust
Hull, England, United Kingdom
- King George Hospital
Ilford, Essex, England, United Kingdom
- Ipswich Hospital
Ipswich, England, United Kingdom
- West Middlesex University Hospital
Isleworth, England, United Kingdom
- Kidderminster Hospital
Kidderminster Worcestershire, England, United Kingdom
- Royal Albert Edward Infirmary
Lancanshire, England, United Kingdom
- Royal Lancaster Infirmary
Lancaster, England, United Kingdom
- Cookridge Hospital
Leeds, England, United Kingdom
- Lincoln County Hospital
Lincoln, England, United Kingdom
- Aintree University Hospital
Liverpool, England, United Kingdom
- Charing Cross Hospital
London, England, United Kingdom
- Helen Rollason Cancer Care Centre at North Middlesex Hospital
London, England, United Kingdom
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- St. George'S Hospital
London, England, United Kingdom
- Ucl Cancer Institute
London, England, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2004
- Primary completion
- 31 Mar 2008
- Completion
- —
- Last update posted
- 26 Aug 2013
- Registered enrollment
- 800
- Registry id
- NCT00427713
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.